EXCHANGE TRADED CONCEPTS, LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXCHANGE TRADED CONCEPTS, LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2023$654,976
+5.4%
26,7010.0%0.02%
-5.9%
Q1 2023$621,332
-49.6%
26,701
-45.1%
0.02%
-51.4%
Q4 2022$1,231,610
+35.3%
48,661
+3.1%
0.04%
+16.7%
Q3 2022$910,000
+10011.1%
47,181
+27491.2%
0.03%
Q1 2021$9,0001710.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$38,245,75330.44%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$409,259,5263.12%
Octagon Capital Advisors LP 650,100$15,946,9532.22%
Paradigm Biocapital Advisors LP 1,014,239$24,879,2831.92%
Perceptive Advisors 1,958,264$48,036,2161.39%
Avidity Partners Management LP 1,425,000$34,955,2501.22%
Ghost Tree Capital, LLC 150,000$3,679,5001.22%
MIRABELLA FINANCIAL SERVICES LLP 412,008$10,106,5561.11%
SECTOR GAMMA AS 150,406$3,689,4590.83%
Sofinnova Investments, Inc. 488,117$11,973,5100.78%
View complete list of VIR BIOTECHNOLOGY INC shareholders